Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non–Small Cell Lung Cancer - Concepedia

Concepedia

Publication | Closed Access

Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non–Small Cell Lung Cancer

181

Citations

15

References

2018

Year

Yi‐Long Wu, Shun Lü, You Lü, Jianying Zhou, Yuankai Shi, Virote Sriuranpong, Chun‐Ming Tsai, Chin‐Hee Chung, Keith D. Wilner, Yiyun Tang,

Journal of Thoracic Oncology

References

	Year	Citations

Page 1